In the latest draft guidance, USFDA tried to tackle a major loophole called #39;citizen petitions#39; used by branded drug makers or innovators to delay the entry of generic drugsfrom Moneycontrol Business News https://ift.tt/2P7dfNJ
Tuesday, October 2, 2018
US drug regulator issues guidance to tackle delays speed-up generic approvals
In the latest draft guidance, USFDA tried to tackle a major loophole called #39;citizen petitions#39; used by branded drug makers or innovators to delay the entry of generic drugsfrom Moneycontrol Business News https://ift.tt/2P7dfNJ
Subscribe to:
Post Comments (Atom)
-
The value had touched a high of 22% of total market capitalisation of listed firms in June 2009, dropping to a low of 5.1% in September 2020...
-
Huawei faces international scrutiny over its ties with the Chinese government and suspicion that Beijing could use Huawei#39;s technology f...
No comments:
Post a Comment